AKAP1 and cardiac hypertrophy: Furthermore, the authors showed by breeding transgenic mice overexpressing a disruptor peptide that inhibition of AKAP-Lbc/p38 complex reduces cardiomyocyte hypertrophy, proving for the first time an in vivo role of AKAP in regulating cardiac hypertrophy (Pérez López et al., 2013).